학술논문
O-12 NCI9673 (Part B): A multi-institutional ETCTN randomized phase II study of nivolumab with or without ipilimumab in refractory, metastatic squamous cell carcinoma of the anal canal
Document Type
Abstract
Author
Source
In Annals of Oncology June 2023 34 Supplement 1:S185-S186
Subject
Language
ISSN
0923-7534